Adult Giant Cell Glioblastoma Active Not Recruiting Phase 2 Trials for Trebananib (DB12056)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01609790Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain TumorsTreatment